Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to $1.0 million.

  • Autolus Therapeutics' Other Non-Current Assets fell 0.19% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 0.19%. This contributed to the annual value of $963,000 for FY2024, which is 2.03% down from last year.
  • Autolus Therapeutics' Other Non-Current Assets amounted to $1.0 million in Q3 2025, which was down 80.39% from $5.3 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Other Non-Current Assets registered a high of $5.3 million during Q2 2025, and its lowest value of $811,000 during Q2 2021.
  • For the 3-year period, Autolus Therapeutics' Other Non-Current Assets averaged around $1.6 million, with its median value being $1.0 million (2025).
  • In the last 5 years, Autolus Therapeutics' Other Non-Current Assets crashed by 54.83% in 2023 and then soared by 438.18% in 2025.
  • Over the past 5 years, Autolus Therapeutics' Other Non-Current Assets (Quarterly) stood at $2.4 million in 2021, then dropped by 7.87% to $2.2 million in 2022, then tumbled by 54.83% to $983,000 in 2023, then decreased by 2.03% to $963,000 in 2024, then decreased by 0.19% to $1.0 million in 2025.
  • Its Other Non-Current Assets stands at $1.0 million for Q3 2025, versus $5.3 million for Q2 2025 and $993,000 for Q1 2025.